Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues

Bioorganic & Medicinal Chemistry Letters
1998.0

Abstract

New bisantrene analogues were synthesized, bearing one or two 4,5-dihydro-1H-imidazol-2-yl hydrazone side chains at positions 1,4 or 9 of the anthracene ring system. A 10-azabioisostere was also prepared. The position of substituents in structurally isomeric drugs modulates topoisomerase II poisoning and specificity, along with cytotoxicity.

Knowledge Graph

Similar Paper

Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues
Bioorganic & Medicinal Chemistry Letters 1998.0
Antitumor agents. II. Bis(guanylhydrazones) of anthracene-9,10-dicarboxaldehydes
Journal of Medicinal Chemistry 1982.0
Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-Aryl-substituted 2-bis-1H-benzimidazoles
European Journal of Medicinal Chemistry 2011.0
The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds
Bioorganic & Medicinal Chemistry 2009.0
Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents
European Journal of Medicinal Chemistry 2016.0
Investigation of the Structure–Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons
Journal of Medicinal Chemistry 2016.0
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines
Bioorganic & Medicinal Chemistry 2010.0
Indenoindolone derivatives as topoisomerase II–inhibiting anticancer agents
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, synthesis and biological evaluation of benzimidazole–rhodanine conjugates as potent topoisomerase II inhibitors
MedChemComm 2018.0
Synthesis, Cytotoxicity, DNA Interaction, and Topoisomerase II Inhibition Properties of Novel Indeno[2,1-c]quinolin-7-one and Indeno[1,2-c]isoquinolin-5,11-dione Derivatives
Journal of Medicinal Chemistry 2008.0